Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
about
Oligonucleotide-directed mutagenesis for precision gene editingReplicative DNA polymerase δ but not ε proofreads errors in Cis and in TransOligo/polynucleotide-based gene modification: strategies and therapeutic potentialSimultaneous targeted exchange of two nucleotides by single-stranded oligonucleotides clusters within a region of about fourteen nucleotides.Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice.Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicityA mouse geneticist's practical guide to CRISPR applications.Functional analysis in mouse embryonic stem cells reveals wild-type activity for three MSH6 variants found in suspected Lynch syndrome patients.Stimulation of oligonucleotide-directed gene correction by Redβ expression and MSH2 depletion in human HT1080 cellsOligonucleotide transformation of yeast reveals mismatch repair complexes to be differentially active on DNA replication strands.Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotideLNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells.Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.Contemporary approaches for modifying the mouse genomeProgress and prospects: targeted gene alteration (TGA).BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Conditional DNA repair mutants enable highly precise genome engineering.Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application.An update on targeted gene repair in mammalian cells: methods and mechanismsTowards artificial metallonucleases for gene therapy: recent advances and new perspectives.Oligonucleotide-directed gene-editing technology: mechanisms and future prospects.Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.Subtle gene modification in mouse ES cells: evidence for incorporation of unmodified oligonucleotides without induction of DNA damage.Parameters of oligonucleotide-mediated gene modification in mouse ES cellsStrand bias influences the mechanism of gene editing directed by single-stranded DNA oligonucleotides.Validation of oligonucleotide-mediated gene editing.Oligonucleotide-Mediated Genome Editing Provides Precision and Function to Engineered Nucleases and Antibiotics in Plants.DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break.Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance.
P2860
Q26778792-F657B410-7754-478D-83F3-D15BD603BD52Q28258327-B1C97FD2-DFA7-4DEA-B492-965D260C7F68Q28307657-FAC6341F-39F0-43A3-B869-1A17421C317DQ33316832-E4C53CE2-3DD2-42D6-940A-EA3FE1D4FE2CQ33411557-147DBD94-E698-473A-82C3-2B4A8F61E701Q33769290-51357C11-D31C-4C90-BB1A-78810EFAB46DQ34441174-28DBE5B1-6797-4FDC-8869-11E73E3F6BA5Q34990339-BADA4428-DFEF-42AD-8317-EE7D37BD89D9Q35039019-1168818F-1BF1-4020-8432-E0DDD7D24520Q36090192-8F20E59A-C564-43DF-B69E-671817398B48Q36727299-DB622FDF-B627-4743-9E49-2FF8F77AA34EQ36821495-AE400B8B-9749-46C1-A2A6-8964CC1028D6Q36821500-D9A12D0D-EA54-4481-A87B-B06123DE3847Q36846842-D67D3405-9C67-494F-B2B7-DE6E166AF2D8Q36986953-44623F63-CC38-4DD4-BDBD-208A32C0A24DQ37137914-DB48D96A-8BF7-4F9D-BC37-BDAF27B79B0CQ37734351-0C36CE41-73A7-4CF7-930F-530E10C20650Q37821231-A5A0BFEF-83D9-49F2-867C-6983FCC087D2Q37834094-188A5008-56E4-4DE9-87E8-888FF06418D5Q37948867-5976A15B-2855-4C2E-89F9-DA472DC04255Q37982821-6584E0CD-271B-4ECD-A4F7-C6C40A16D5C5Q38209315-C62DBFF0-7D73-4DDA-8CE3-710C03470FC2Q39026667-4D4FA1CA-CAF9-47F1-A582-C4DB7049D0AAQ39684456-2C95335D-14B2-4628-A4D7-716F5FFDD3ADQ39821715-8E510583-1997-43C1-9A81-DE314FA9DC26Q41898361-0B46292A-1BEB-4949-AFE0-B4200BBFCCDFQ45884299-3892DB2A-6A85-4FCD-BAE1-EFCD005483FDQ46100766-A3295E58-A0FC-4376-8FED-FDADA37656A1Q49977748-EA65D085-940C-45F1-862B-1F39378D8AA0Q55348060-43611204-EF19-4F7F-8457-62AD2BFD2C29
P2860
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
@en
type
label
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
@en
prefLabel
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells.
@en
P2093
P2860
P356
P1476
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells
@en
P2093
Anja van der Wal
Hein te Riele
Marleen Dekker
Sandra de Vries
P2860
P356
10.1093/NAR/GKL896
P407
P577
2006-11-16T00:00:00Z